JD Health International Inc.
JDHIFOTCHealthcare● Active
$5.85
+$0.00(+0.00%)
Market Cap$18.7B
P/E Ratio—
52W High$8.75
52W Low$3.23
JD Health International Inc. (JDHIF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
JDHIF · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 5, 2026EPS Actual
$0.13
Revenue
$5.45B
Est. $5.34B · +2.1%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 5, 2026
After Market Close
▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
JDHIF reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | $0.17 | — | — | — | $6.10B | — |
| — Q1 FY2026 | Mar 5, 2026 | — | $0.13 | — | $5.45B | $5.34B | +2.1% |
| ▲ Q1 FY2025 | Mar 6, 2025 | $0.09 | $0.09 | +6.7% | $4.08B | $4.05B | +0.7% |
| ▼ Q3 FY2024 | Aug 15, 2024 | $0.09 | $0.09 | -2.2% | $3.90B | $4.04B | -3.4% |
| ▼ Q2 FY2024 | Jun 21, 2024 | $0.06 | $0.03 | -58.5% | $3.73B | $3.64B | +2.3% |
| ▲ Q2 FY2023 | Jun 30, 2023 | $0.05 | $0.07 | +28.4% | $3.74B | $3.83B | -2.3% |
| ▼ Q4 FY2022 | Dec 31, 2022 | $0.05 | $0.01 | -84.0% | $3.87B | $3.55B | +8.9% |
| ▼ Q2 FY2022 | Jun 30, 2022 | $0.03 | $0.01 | -66.9% | $3.02B | $2.89B | +4.4% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
$0.17
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 5, 2026
EPS Actual
$0.13
EPS Est.
—
EPS Surpr.
—
Revenue
$5.45B
Q1 FY2025
Mar 6, 2025Beat
EPS Actual
$0.09
EPS Est.
$0.09
EPS Surpr.
+6.7%
Revenue
$4.08B
Q3 FY2024
Aug 15, 2024Miss
EPS Actual
$0.09
EPS Est.
$0.09
EPS Surpr.
-2.2%
Revenue
$3.90B
Q2 FY2024
Jun 21, 2024Miss
EPS Actual
$0.03
EPS Est.
$0.06
EPS Surpr.
-58.5%
Revenue
$3.73B
Q2 FY2023
Jun 30, 2023Beat
EPS Actual
$0.07
EPS Est.
$0.05
EPS Surpr.
+28.4%
Revenue
$3.74B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
$0.01
EPS Est.
$0.05
EPS Surpr.
-84.0%
Revenue
$3.87B
Q2 FY2022
Jun 30, 2022Miss
EPS Actual
$0.01
EPS Est.
$0.03
EPS Surpr.
-66.9%
Revenue
$3.02B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $19.3B | $19.8B | $20.1B | 3 |
| Q3 FY2025 | $16.5B | $16.6B | $16.6B | 2 |
| Q2 FY2025 | $17.6B | $17.8B | $18.1B | 2 |
| Q4 FY2024 | $16.4B | $16.4B | $16.4B | 1 |
| Q3 FY2024 | $13.3B | $13.3B | $13.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 5, 2026 | — | $6.49 | $6.15 | -5.24% |
| ▲ Q1 FY2025 | Mar 6, 2025 | +6.7% | $3.13 | $3.13 | +0.00% |
| ▼ Q3 FY2024 | Aug 15, 2024 | -2.2% | $3.13 | $3.13 | +0.00% |
| ▼ Q2 FY2024 | Jun 21, 2024 | -58.5% | $3.65 | $3.13 | -14.25% |
| ▲ Q2 FY2023 | Jun 30, 2023 | +28.4% | $6.21 | $6.21 | +0.00% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -84.0% | $9.59 | $9.59 | +0.00% |
| ▼ Q2 FY2022 | Jun 30, 2022 | -66.9% | $6.19 | $6.19 | +0.00% |
| ▼ Q4 FY2021 | Dec 31, 2021 | -213.6% | $7.70 | $7.70 | +0.00% |
Q1 FY2026-5.24%
Report Date
Mar 5, 2026
EPS Beat/Miss
—
Price Before
$6.49
Price After
$6.15
Q1 FY2025+0.00%
Report Date
Mar 6, 2025
EPS Beat/Miss
+6.7%
Price Before
$3.13
Price After
$3.13
Q3 FY2024+0.00%
Report Date
Aug 15, 2024
EPS Beat/Miss
-2.2%
Price Before
$3.13
Price After
$3.13
Q2 FY2024-14.25%
Report Date
Jun 21, 2024
EPS Beat/Miss
-58.5%
Price Before
$3.65
Price After
$3.13
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
+28.4%
Price Before
$6.21
Price After
$6.21
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
-84.0%
Price Before
$9.59
Price After
$9.59
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
-66.9%
Price Before
$6.19
Price After
$6.19
Q4 FY2021+0.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
-213.6%
Price Before
$7.70
Price After
$7.70
Avg Beat Reaction+0.00%
Avg Miss Reaction-2.85%
Beat Rate2 / 8 quarters
Largest Move-14.25% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: JDHIF ends December
JD Health International Inc. (JDHIF) most recently reported earnings on March 5, 2026 for Q1 FY2026, posting EPS of $0.13 (in line with the analyst consensus of —). The next JDHIF earnings date is expected around September 1, 2026.
Each quarter, investors track JDHIF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. JDHIF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
JDHIF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
JDHIF earnings · 4 questionsJD Health International Inc.'s next earnings report is expected around September 1, 2026. JDHIF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; JDHIF historically reports after market close (AMC).
JDHIF earnings datewhen is JDHIF earningsJDHIF next earnings datewhen does JDHIF report earningsJDHIF earnings calendar
▸ Source: FMP · JD Health International Inc. SEC filings · US GAAP · JD Health International Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026